Guardant Health, Inc. (GH) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 22.22B USD. 52-week range 61.00 to 191.05 USD. Data as of 2026-10-09.
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling ...